title: Helicobacter pylori Resists the Antimicrobial Activity of Calprotectin via Lipid A Modification and Associated Biofilm Formation.
abstract: Helicobacter pylori is one of several pathogens that persist within the host despite a robust immune response. H. pylori elicits a proinflammatory response from host epithelia, resulting in the recruitment of immune cells which manifests as gastritis. Relatively little is known about how H. pylori survives antimicrobials, including calprotectin (CP), which is present during the inflammatory response. The data presented here suggest that one way H. pylori survives the nutrient sequestration by CP is through alteration of its outer membrane. CP-treated H. pylori demonstrates increased bacterial fitness in response to further coculture with CP. Moreover, CP-treated H. pylori cultures form biofilms and demonstrate decreased cell surface hydrophobicity. In response to CP, the H. pylori Lpx lipid A biosynthetic enzymes are not fully functional. The lipid A molecules observed in H. pylori cultures treated with CP indicate that the LpxF, LpxL, and LpxR enzyme functions are perturbed. Transcriptional analysis of lpxF, lpxL, and lpxR indicates that metal restriction by CP does not control this pathway through transcriptional regulation. Analyses of H. pylori lpx mutants reveal that loss of LpxF and LpxL results in increased fitness, similar to what is observed in the presence of CP; moreover, these mutants have significantly increased biofilm formation and reduced cell surface hydrophobicity. Taken together, these results demonstrate a novel mechanism of H. pylori resistance to the antimicrobial activity of CP via lipid A modification strategies and resulting biofilm formation.
  
  
  OBJECTIVE
  Helicobacter pylori evades recognition of the host's immune system by modifying the lipid A component of lipopolysaccharide. These results demonstrate for the first time that the lipid A modification pathway is influenced by the host's nutritional immune response. H. pylori's exposure to the host Mn- and Zn-binding protein calprotectin perturbs the function of 3 enzymes involved in the lipid A modification pathway. Moreover, CP treatment of H. pylori, or mutants with an altered lipid A, exhibit increased bacterial fitness and increased biofilm formation. This suggests that H. pylori modifies its cell surface structure to survive under the stress imposed by the host immune response. These results provide new insights into the molecular mechanisms that influence the biofilm lifestyle and how endotoxin modification, which renders H. pylori resistant to cationic antimicrobial peptides, can be inactivated in response to sequestration of nutrient metals.
authors.affiliation: Veterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Gaddy
authors.affiliation: Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
authors.forename: Jana N
authors.initials: JN
authors.lastname: Radin
authors.affiliation: Institute of Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, USA.
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Cullen
authors.affiliation: Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.
authors.forename: Walter J
authors.initials: WJ
authors.lastname: Chazin
authors.affiliation: Veterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
authors.forename: Eric P
authors.initials: EP
authors.lastname: Skaar
authors.affiliation: Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
authors.forename: M Stephen
authors.initials: MS
authors.lastname: Trent
authors.affiliation: Veterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA holly.m.algood@vanderbilt.edu.
authors.forename: Holly M S
authors.initials: HM
authors.lastname: Algood
mesh_terms: D000217:Acyltransferases / Q000235:genetics / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development; D002462:Cell Membrane; D024881:Drug Resistance, Bacterial; D016480:Helicobacter pylori / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D057927:Hydrophobic and Hydrophilic Interactions / Q000187:drug effects; D039841:Leukocyte L1 Antigen Complex / Q000494:pharmacology*; D008050:Lipid A / Q000737:chemistry* / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000737:chemistry; D010641:Phenotype
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D039841:Leukocyte L1 Antigen Complex; D008050:Lipid A; D008070:Lipopolysaccharides; D000217:Acyltransferases; C118473:LpxL protein, bacteria